Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

How pre-TAVR PCI impacts patient outcomes

One-year outcomes are similar when patients undergo PCI prior to TAVR—except for one important difference. 

Thumbnail

TEER associated with ‘important and significant’ reductions in hospitalization rates

Considering the study's high-risk patient population, researchers were especially impressed by these one-year outcomes.

Thumbnail

98% of new TAVR programs are being developed in wealthier metro areas

The study's authors examined new TAVR programs established from 2012 to 2018.

Thumbnail

TAVR delivers better outcomes for low-risk patients than a sutureless surgical approach

The two treatment options were comparable in many ways—but TAVR was better when it came to limiting hospitalizations for heart failure. 

Half-dose DOAC improves outcomes after LAAO

The new-look anticoagulation strategy was associated with a significant reduction in adverse outcomes.

radiology reporting EHR health record CDS AUC

Clinicians have a new tool for predicting TAVR mortality

Left atrium emptying fraction (LAEF) measurements can provide significant value during the TAVR planning process.

Thumbnail

High-quality care is helping women with heart defects have safer pregnancies

Early counseling should be stressed for women with congenital heart defects, according to the analysis. 

Real-world TAVR outcomes highlight the accuracy of clinical trials

Clinical trial results don't always apply to real-world patient populations.

Displaying 529 - 536 of 879
Design by Adaptive Theme